Author Topic: Roche faces UK pricing row over Ocrevus  (Read 53 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8247
  • MS diagnosed 1980
  • Location: Pacific Northwest
Roche faces UK pricing row over Ocrevus
« on: September 10, 2018, 02:19:35 pm »

The NICE people, responsible for who gets what medicines through the UK's health service, have decided that Ocrevus for PPMS isn't "cost effective," and so Ocrevus will be covered for RRMS but not for PPMS in the UK unless this matter can be settled differently:

https://www.reuters.com/article/us-roche-britain/roche-faces-uk-pricing-row-over-multiple-sclerosis-drug-ocrevus-idUSKCN1LP0UX
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

Offline agate

  • Administrator
  • *****
  • Posts: 8247
  • MS diagnosed 1980
  • Location: Pacific Northwest
The NICE people have decided to postpone their decision on whether to cover Ocrevus for PPMS in the UK, and that is good news for those with PPMS who have been hoping to be able to obtain this drug.


From Multiple Sclerosis News Today, November 2, 2018--"NICE postpones 'final opinon' on adding Ocrevus to NHS for PPMS patients in UK":


https://multiplesclerosisnewstoday.com/2018/11/02/nice-postpones-final-opinion-on-adding-ocrevus-to-nhs-for-ppms-patients-in-uk/
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
1 Replies
109 Views
Last post June 14, 2017, 10:35:24 am
by agate
1 Replies
70 Views
Last post May 25, 2017, 05:16:24 pm
by agate
0 Replies
63 Views
Last post July 22, 2017, 04:28:55 pm
by agate
0 Replies
76 Views
Last post February 19, 2018, 07:47:49 am
by agate
0 Replies
50 Views
Last post April 06, 2018, 06:37:14 am
by agate